← FDA Drug Approvals (Drugs@FDA)

NADOLOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2015-12-18

Drug application

FDA Application #

ANDA203455

Application type

Abbreviated New Drug Application (Generic)

Brand name

NADOLOL

Generic name

NADOLOL

Active ingredients

NADOLOL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Cipla USA Inc.

First approval

2015-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown